Humanscape signs quadripartite MOU for building PGHD sharing platform

HUM | 06.10| 763

Humanscape signed quadripartite MOU with Green Cross Genome (GC Genome), Cipherome and Seoul National University College of Medicine, for building PGHD sharing platform on May 22nd.

(From the left) Chang-Seok Ki, GC Genome Representative Director / Stephen Chang, CEO of Humanscape / Yong-Ho In, Vice president of Cipherome / Ju-Han Kim, Professor and Founding Chairs of the Division of Biomedical Informatics of Seoul National University, College of Medicine

This quadripartite MOU includes ▲Rare diseases genetic analysis and relevant information sharing ▲Cooperation for building rare disease patient data collecting platform and data acquisition ▲Pharmacogenetic analysis and relevant data sharing ▲IRB application and more.

Thanks to this MOU, Humanscape will be able to build a sophisticated data platform with GC Genome’s genetic analysis technology and Cipherome’s drug suitability prediction technology, which can provide precise pharmacogenetic analysis to decide drug suitability for patients and systematically compile such data for further drug development research. Therefore, patients participating in our Humanscape platform will be given with meaningful benefit, more than just financial incentives.

GC Genome is a a genome analysis specialist that aims to use genome analysis information for disease diagnosis and prediction, and personalized treatment.
Cipherome is a biotech venture company located in San Jose, California, which conducts comprehensive research and develops related technologies by integrating individuals’ genetic information and certain medicine’s working mechanism in order to predict suitability of drugs for patients. Cipherome performs genetic sequencing and compares them with all existing types of drug metabolism to find individuals’ drug sensitivity, providing medical staffs with reference data for personalized prescription.

The four entities will proceed the joint research with the launch of Humanscape’s new service for RP patients.

Get to know us better!
Join our official channels below.

Telegram(EN) :
KakaoTalk(KR) :
Website :
Medium :
Facebook :
Twitter :
Reddit :
Bitcointalk announcement :
Email :

Humanscape signs quadripartite MOU for building PGHD sharing platform was originally published in Humanscape on Medium, where people are continuing the conversation by highlighting and responding to this story.

Comment 0


Are you sure you want to delete this post?